RNAi expression constructs
US8993530B2 · kind B2 · utility
0Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 2011 |
| Grant date | Mar 31, 2015 |
| Priority date | — |
| Expiry date | Aug 23, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24211
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.